<SEC-DOCUMENT>0000856982-25-000050.txt : 20251017
<SEC-HEADER>0000856982-25-000050.hdr.sgml : 20251017
<ACCEPTANCE-DATETIME>20251017160340
ACCESSION NUMBER:		0000856982-25-000050
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20251015
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20251017
DATE AS OF CHANGE:		20251017

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MERIT MEDICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000856982
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				870447695
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18592
		FILM NUMBER:		251400781

	BUSINESS ADDRESS:	
		STREET 1:		1600 WEST MERIT PARK WAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
		BUSINESS PHONE:		8012531600

	MAIL ADDRESS:	
		STREET 1:		1600 WEST MERIT PARKWAY
		CITY:			SOUTH JORDAN
		STATE:			UT
		ZIP:			84095
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mmsi-20251015x8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 11.1.0.0 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 10/17/2025 3:57:58 PM -->
<!-- iXBRL Library version: 1.0.9397.4506 -->
<!-- iXBRL Service Job ID: e2d99f3d-f9fd-4c7c-b76b-a40117347e8d -->
<html xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mmsi="http://www.meritmedical.com/20251015" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html"/><title>Merit Medical Systems,&#160;Inc._October 15, 2025</title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityCentralIndexKey" id="Tc_h6iQ8IudOk6ynxSmtdpOPg_2_1">0000856982</ix:nonNumeric><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:AmendmentFlag" id="Tc_Y1OhEsJcSESd0zZXucP2dg_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="mmsi-20251015.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000856982</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-10-15</xbrli:startDate><xbrli:endDate>2025-10-15</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:27.35pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;min-height:50.24pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><a id="_ad6ff9e0_3e1b_4c81_ab05_390e6a9d2906"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:DocumentType" id="Narr_PeEobsZFCUmeN3PI8pEwJg"><b style="font-weight:bold;">8-K</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:11pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;">Date of Report (date of earliest event reported): </span><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt:date-monthname-day-year-en" name="dei:DocumentPeriodEndDate" id="Narr_RiGWjHkifkWlwYP1SMoYaQ"><span style="font-size:9pt;">October 15, 2025</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><img src="mmsi-20251015x8k001.jpg" alt="Graphic" style="display:inline-block;height:50.24pt;width:279.71pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityRegistrantName" id="Narr_Cp4ESXKYTkClvDG-eVuX5w"><b style="font-weight:bold;">Merit Medical Systems,&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_482e885a_2d52_4623_b7e4_21eef4425b9e"></a><a id="Tc_lPnYXDByW06Nc32jL7ZFtg_2_0"></a><a id="Tc_9BXk3OQ6cEWEHar81wkweA_2_2"></a><a id="Tc_3oLWJ9p3o0aHolHY0aYW9A_2_4"></a><a id="Tc_Du5sHiN5-kSBAnvSm_Ay4g_3_0"></a><a id="Tc_BQB3qJmqeE2_8KWLI05Ljg_3_2"></a><a id="Tc_3OwBX-0WREiDIW_iBfXkBg_3_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_0QYXtQzqrkmlkOHneteSXA_1_0"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityFileNumber" id="Tc_L5M78zxbOES_JlG4BI5T1Q_1_2"><b style="font-size:9pt;font-weight:bold;">0-18592</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityTaxIdentificationNumber" id="Tc_JknZHsZx9UCPS2VBQCxWpg_1_4"><b style="font-size:9pt;font-weight:bold;">87-0447695</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(State or other jurisdiction of</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Commission</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(I.R.S. Employer</p></td></tr><tr><td style="vertical-align:bottom;width:38.04%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">incorporation or organization)</p></td><td style="vertical-align:bottom;width:2.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:23.6%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">File Number)</p></td><td style="vertical-align:bottom;width:2.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:33.19%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Identification No.)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_7d471683_06d1_45fe_9287_288340eace6c"></a><a id="Tc_FYnRIkG7dUK53ZbWOJzYSA_2_0"></a><a id="Tc_A5REloFrDESUJH6VcPfMoA_3_0"></a><a id="Tc_r2LbFuAerk6LmrkS2N6kGg_3_2"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityAddressAddressLine1" id="Tc_rJIaT4g3jEWS-lDfsL-Fjw_1_0"><b style="font-size:9pt;font-weight:bold;">1600 West Merit Parkway</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityAddressCityOrTown" id="Narr_4AE7UOaOpk24VuR1R8bMFg"><b style="font-size:9pt;font-weight:bold;">South Jordan</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_S_vQ-qoSMkiRLlzK-LFHcA"><b style="font-size:9pt;font-weight:bold;">Utah</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:EntityAddressPostalZipCode" id="Tc_LLSe1xf-KEyyYzokxveY5A_2_2"><b style="font-size:9pt;font-weight:bold;">84095</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:bottom;width:50.97%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Address of principal executive offices)</p></td><td style="vertical-align:bottom;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:46.96%;margin:0pt;padding:0pt 3pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Zip Code)</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:9pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:CityAreaCode" id="Narr_q2X3HmtVz0y1eLnTGpC-Og"><b style="font-size:9pt;font-weight:bold;">801</b></ix:nonNumeric><b style="font-size:9pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:LocalPhoneNumber" id="Narr__AQ3VdovS0mk_ZKpZFinWA"><b style="font-size:9pt;font-weight:bold;">253-1600</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Registrant's telephone number, including area code)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">N/A</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_MIR3jIR7uEyB2wgNlFHm1w"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr_i8hoaXdu-EeKIpdi4thLPA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_Do9t8_MpSEySroVl-u3x2A"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_WlyWk8XlA0a4Z4AVizavtA"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric><span style="font-size:9pt;">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-align:justify;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><a id="_e1adca4e_7a42_4339_9783_775404ac1f0f"></a><a id="Tc_X-dsm37bMUOZRt5XsKakfA_1_0"></a><a id="Tc_hlWjl4brpUe3dqRoMgDOUA_1_2"></a><a id="Tc_hyfeE45rXES6SuzQvlP7dw_1_4"></a><a id="Tc_N9AQCDRfnU-1hqITCdRj2g_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;table-layout:auto;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Title&#160;of&#160;each&#160;class</p></td><td style="vertical-align:bottom;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:20.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Trading&#160;Symbol(s)</p></td><td style="vertical-align:bottom;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;width:42.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which&#160;registered</p></td></tr><tr><td style="vertical-align:top;width:31.7%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:Security12bTitle" id="Tc_q_E3GkRBTk-FlmAN5DhzDQ_2_0"><span style="font-size:9pt;">Common Stock, no par value</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:2.49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:20.06%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:TradingSymbol" id="Tc_9GqSklqLPk-Z3JE-pDj_Ww_2_2"><span style="font-size:9pt;">MMSI</span></ix:nonNumeric></p></td><td style="vertical-align:top;width:3.33%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:42.39%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" name="dei:SecurityExchangeName" id="Narr_-Q8uExkNm02dM63Vov-0qw"><span style="font-size:9pt;">NASDAQ</span></ix:nonNumeric><span style="font-size:9pt;"> Global Select Market</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;">Emerging growth company&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_GMrdmmNx-Emx0CtI0iUo6A"><span style="font-family:'Segoe UI Symbol';font-size:9pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:6pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-family:'Segoe UI Symbol';font-size:9pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_6373cea9_ce6c_416e_82d9_33a18b36fc2e"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item 7.01 Regulation FD Disclosure</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">On October 15, 2025, Merit Medical Systems, Inc. (&#8220;Merit&#8221;) issued a press release (the &#8220;Acquisition Press Release&#8221;) announcing it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX&#174; Medical, Inc., to acquire the C2 CryoBalloon&#8482; device and related technology. The closing of the proposed transaction is expected to occur during the fourth quarter of 2025, subject to the satisfaction or waiver (in accordance with the provisions of the asset purchase agreement) of certain customary closing conditions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Merit proposes to acquire the C2 CryoBalloon assets from Pentax of America, Inc. for total purchase consideration of $22 million, consisting of a $19 million cash payment at closing and potential contingent payments of up to $3 million payable upon meeting certain milestones.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">A copy of the Acquisition Press Release is included as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Merit is making reference to non-GAAP information in the Acquisition Press Release. A quantitative reconciliation of such non-GAAP financial information to comparable GAAP financial information is not available without unreasonable effort.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The information contained in this Item 7.01 of this Current Report and in the attached Exhibit 99.1 is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by Merit under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The information included in this Current Report contains forward-looking statements about Merit that involve substantial risks and uncertainties. Merit intends such statements, and all subsequent forward-looking statements attributable to Merit, to be expressly qualified in their entirety by these cautionary statements and covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Exchange Act and Section 27A of the Securities Act. In some cases, forward-looking statements can be identified by the use of terminology such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;forecast,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;objective&#8221; or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology. However, not all forward-looking statements contain such identifying words. All statements included in this Current Report, other than statements of historical fact, are forward-looking statements for purposes of the Exchange Act and the Securities Act, including any projections of earnings, revenues or other financial items, any statements of the plans and objectives for future operations, any statements concerning proposed new products or services, any statements regarding the integration, development or commercialization of the business or any assets acquired from other parties, any statements regarding future economic conditions or performance, and any statements of assumptions underlying any of the foregoing. Additionally, forward-looking statements include, among other things, inherent risks and uncertainties associated with Merit&#8217;s proposed acquisition of the C2 CryoBalloon device and related technology, Merit&#8217;s integration of the assets and operations proposed to be acquired from PENTAX Medical and its ability to achieve projected financial results, product development and other anticipated benefits of the proposed acquisition, and uncertainties as to whether Merit will achieve sales, gross and operating margin, net income and earnings per share performance consistent with its forecasts projected for the assets and operations proposed to be acquired from PENTAX Medical.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Merit&#8217;s actual results, levels of activity, performance or achievement to be materially different from those expressed or implied by these forward-looking statements, including those risks, uncertainties and other factors described in Merit&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 and Merit&#8217;s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025, and subsequent filings with the SEC.</p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">All forward-looking statements included in this Current Report speak only as of the date made, are based on information available to Merit as of such date, and are subject to change. Merit assumes no obligation to update or revise any forward-looking statement. If Merit does update or correct one or more forward-looking statements, readers should not conclude that Merit will make additional updates or corrections. Merit&#8217;s actual results will likely differ, and may differ materially, from anticipated results. Readers should not unduly rely on any such forward-looking statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_087588e2_e158_4898_b819_73380f39ae9d"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Item 9.01. &#160;Financial Statements and Exhibits.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:19.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:1.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:78.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:34.5pt;"><td style="vertical-align:bottom;width:19.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">EXHIBIT&#160;NUMBER</b></p></td><td style="vertical-align:top;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;width:78.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">DESCRIPTION</b></p></td></tr><tr style="height:8.15pt;"><td style="vertical-align:top;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:78.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;background:#ffff00;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">99.1</p></td><td style="vertical-align:top;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:78.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;"><span style="font-size:9.5pt;">Press Release, dated October 15</span><span style="font-size:10pt;">, 2025</span><span style="font-size:9.5pt;">, entitled &#8220;</span><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="mmsi-20251015xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to acquire C2 CryoBalloon Technology</span><span style="font-family:'Times New Roman','Times','serif';font-size:9.5pt;font-style:normal;font-weight:normal;">.</span></a><span style="font-size:9.5pt;">&#8221;</span></p></td></tr><tr><td style="vertical-align:top;width:19.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">104</p></td><td style="vertical-align:top;width:1.95%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:78.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.43;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_111f7eeb_2102_42cb_820f_f6e7d4f4d14b"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;width:49.8%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">MERIT MEDICAL SYSTEMS,&#160;INC.</b></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Date: October 17, 2025</p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">By:</p></td><td style="vertical-align:bottom;width:45.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="text-decoration-color:#000000;">/s/ Brian G. Lloyd</span></p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;border-top:1px solid #000000;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Brian G. Lloyd</p></td></tr><tr><td style="vertical-align:bottom;width:50.19%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:4.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:45.7%;margin:0pt;padding:0pt 2pt 0pt 0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Chief Legal Officer and Corporate Secretary</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>mmsi-20251015xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.1.0.82--><!--Created on: 10/17/2025 03:57:56 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 0pt 7.5pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXHIBIT 99.1</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><a name="_Hlk54257290"></a><a name="_Hlk529444201"></a><font style="font-family:'Times New Roman','Times','serif';"><img src="mmsi-20251015xex99d1001.jpg" alt="Graphic" style="display:inline-block;height:75.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:468pt;"></font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to acquire C2 CryoBalloon Technology </b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Asset acquisition would expand Merit&#8217;s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders.&#160;</i></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">Asset acquisition is projected to add approximately $6 million to $8 million of revenue in 2026 in a key gastroenterology market that leverages Merit&#8217;s existing commercial footprint.</i></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has signed a definitive asset purchase agreement with Pentax of America, Inc., a subsidiary of PENTAX&#174; Medical, Inc., to acquire the C2 CryoBalloon&#8482; device and related technology. The closing of the proposed transaction is expected to occur during the fourth quarter of 2025, subject to the receipt or waiver (in accordance with the provisions of the asset purchase agreement) of certain customary closing conditions.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;The proposed acquisition reflects Merit&#8217;s commitment to advancing minimally invasive solutions for gastrointestinal disorders. We&#8217;re excited to welcome new team members and expand our portfolio, empowering physicians to improve patient outcomes worldwide,&#8221; said Martha G. Aronson, Merit&#8217;s President and CEO.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">The proposed acquisition is intended to strengthen Merit&#8217;s position in the gastroenterology market and provide opportunities to treat more patients suffering from the effects of chronic gastroesophageal reflux disease (GERD) and other gastrointestinal tissue disorders. The C2 CryoBalloon delivers controlled freezing treatments to drive targeted ablation and precise destruction of unwanted soft tissue.  </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">A common digestive disorder, GERD occurs when the lower esophageal sphincter does not tighten correctly, allowing acid from the stomach to enter the esophagus. When this occurs chronically, it can result in serious health conditions, such as esophageal damage, Barrett&#8217;s esophagus, and cancer. The C2 CryoBalloon treats Barrett&#8217;s esophagus, as well as a less-common vascular disorder, gastric antral vascular ectasia (GAVE) syndrome, by freezing and eliminating abnormal cells while still maintaining the integrity of surrounding tissue structures. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;We believe this purchase will help our team optimize commercial activities in the multibillion-dollar gastroenterology market and provide physicians with more options to help care for their patients,&#8221; said Fred P. Lampropoulos, Merit&#8217;s Chairman of the Board. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;C2 technology has been an exciting part of PENTAX Medical&#8217;s journey since 2017. The C2 CryoBalloon holds promise across a range of therapeutic applications. We are pleased to announce that Merit will be the new home for C2, unlocking its potential,&#8221; stated Dominique Vincent, President of PENTAX Medical. &#8220;With its expanding footprint in upper gastrointestinal treatments and deep expertise in the field, Merit is ideally positioned to accelerate C2&#8217;s growth, making it available to even more patients and clinicians worldwide.&#8221;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Merit intends to integrate the C2 CryoBalloon business into its Endoscopy portfolio, complementing its existing products and customer base. </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Over the next few months, Merit plans to transfer product manufacturing to its facility in South Jordan, Utah. Merit anticipates that some of the PENTAX employees currently engaged in the C2 CryoBalloon business will be joining Merit, bringing their knowledge and expertise to the team. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Financial Summary</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Merit proposes to acquire the C2 CryoBalloon assets from Pentax of America, Inc. for total purchase consideration of $22 million, consisting of a $19 million cash payment at closing and potential contingent payments of up to $3 million payable upon meeting certain milestones. The acquired assets are projected to contribute revenue, from a projected closing date of November 1, 2025 through December 31, 2025, of approximately $1 million and are projected, during the same period of time, to dilute Merit&#8217;s previously forecasted non-GAAP net income and non-GAAP earnings per share, by approximately $0.4 million and $0.01, respectively. The acquisition is projected to be dilutive to Merit&#8217;s full-year 2025 GAAP net income and GAAP earnings per share by approximately $0.5 million and $0.01, respectively. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The proposed acquisition is projected to contribute revenue in the range of approximately $6 million to $8 million for the twelve months ending December 31, 2026, and to be dilutive to Merit&#8217;s non-GAAP net income and non-GAAP earnings per share in the range of approximately $1 million to $2 million, or $0.02 - $0.03 per share, respectively, and to be accretive thereafter. The proposed acquisition is projected to be dilutive to Merit&#8217;s GAAP net income and GAAP earnings per share in the range of approximately $2 million to $3 million, or $0.03 - $0.05 per share, respectively.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Non-GAAP net income and non-GAAP earnings per share are non-GAAP financial measures. A quantitative reconciliation of the impacts on such financial measures as set forth above to the impacts on comparable GAAP financial measures is not available without unreasonable effort.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Advisors</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">JP Morgan Chase &amp; Co. acted as financial advisor to PENTAX Medical.  Parr Brown Gee &amp; Loveless served as legal advisor to Merit. Morrison &amp; Foerster LLP served as legal advisor to PENTAX Medical.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Non-GAAP Financial Measures</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;padding-bottom:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">Merit generally does not provide guidance for GAAP reported financial measures (other than revenue) or a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures (other than revenue) because Merit is unable to predict with reasonable certainty the financial impact of various items which could impact Merit&#8217;s future financial results, such as expenses attributable to acquisitions or other extraordinary transactions, non-cash expenses related to amortization or write-off of previously acquired tangible and intangible assets, certain employee termination benefits, performance-based stock compensation expenses, expenses resulting from non-ordinary course litigation or administrative proceedings and resulting settlements, governmental proceedings, and changes in governmental or industry regulations. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. For the same reasons, Merit is unable to address the significance of the unavailable information, which could be material to future results. Specifically, Merit is not, without unreasonable effort, able to reliably predict the impact of these items and Merit believes inclusion of a reconciliation of these forward-looking non-GAAP measures to their GAAP counterparts could be confusing to investors or cause undue reliance.  Only information on the impacts to such measures from the proposed acquisition is being included in this release, a reconciliation of the impacts on such financial measures to the impacts on their GAAP counterparts is not available without unreasonable effort.</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ABOUT MERIT MEDICAL&#160;</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt 0pt 10pt 0pt;">Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves customers worldwide with a domestic and international sales force and clinical support team totaling more than 800 individuals. Merit employs approximately 7,400 people worldwide.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ABOUT PENTAX MEDICAL</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">PENTAX Medical, a division of the HOYA Group, is a global player in flexible, reusable endoscopy solutions. The company develops, manufactures, distributes, and services endoscopic equipment worldwide. PENTAX Medical is committed to delivering intuitive, flexible endoscopy solutions that empower healthcare professionals to provide outstanding care.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Its mission is to maintain product excellence while collaborating closely with clinical partners to understand and address their daily challenges, workflows, and goals. At the core of this mission is a commitment to reliability and high-quality imaging&#8212;fundamental requirements for clinical performance. Building on this foundation, PENTAX Medical delivers solutions that integrate seamlessly into clinical practice, supported by ergonomic and ease-of-use innovations, practical clinical education, and personalized, attentive customer support. </font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">For more information, please visit: (https://www.pentaxmedical.com).</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">ABOUT HOYA</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;padding-bottom:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">HOYA Corporation, founded in Tokyo in 1941, is a global leader in healthcare and technology innovation. HOYA provides advanced products for life care, including eyeglass lenses, intraocular lenses, and medical endoscopes, as well as high-precision components that support today`s information society, such as mask blanks for semiconductor manufacturing, glass substrates for hard disk drives, and optical components for imaging systems. With over 150 offices worldwide and a team of approximately 38,000 professionals, HOYA is committed to advancing technologies that contribute to a more sustainable future. For more details, please visit: (https://www.hoya.com/en/).</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.37;padding-bottom:8pt;background:#ffffff;margin:0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;background:#ffffff;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others:</font></p><div style="margin-top:14pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt 0pt 10pt 0pt;">&#9679;</td><td style="padding:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Statements proceeded or followed by, or that include the words, &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;forecasts,&#8221; &#8220;potential,&#8221; &#8220;target,&#8221; &#8220;continue,&#8221; &#8220;upcoming,&#8221; &#8220;optimistic&#8221; or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt 0pt 10pt 0pt;">&#9679;</td><td style="padding:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Statements that address Merit&#8217;s future operating performance or events or developments that Merit&#8217;s management expects or anticipates will occur, including, without limitation, any statements regarding Merit&#8217;s projected revenues, earnings or other financial measures, Merit&#8217;s plans and objectives for future operations, Merit&#8217;s proposed new products or services, the integration, development or commercialization of the business or any assets acquired from other parties, future economic conditions or performance, the implementation of, and results which may be achieved through, Merit&#8217;s Continued Growth Initiatives Program or other business optimization initiatives, and any statements of assumptions underlying any of the foregoing; and</font></td></tr></table></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.37;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;background:#ffffff;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Statements regarding Merit&#8217;s past performance, efforts, or results about which inferences or assumptions may be made, including statements proceeded or followed by the words &quot;preliminary,&quot; &quot;initial,&quot; &quot;potential,&quot; &quot;possible,&quot; &quot;diligence,&quot; &quot;industry-leading,&quot; &quot;compliant,&quot; &quot;indications,&quot; or &quot;early feedback&quot; or other forms of these words or similar words or expressions, or the negative thereof or other comparable terminology.</font></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;padding-bottom:10pt;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The forward-looking statements contained in this release are based on Merit management&#8217;s current expectations and assumptions regarding future events or outcomes. If underlying expectations or assumptions prove inaccurate, or risks or uncertainties materialize, actual results will likely differ, and could differ materially, from Merit&#8217;s expectations reflected in any forward-looking statements. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Investors are cautioned not to unduly rely on any such forward-looking statements.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following are some of the important risks and uncertainties that could cause Merit&#8217;s actual results to differ from Merit&#8217;s expectations in any forward-looking statements: inherent risks and uncertainties associated with Merit&#8217;s proposed acquisition of the C2 CryoBalloon device and related technology; Merit&#8217;s integration of the assets and operations proposed to be acquired from PENTAX Medical and its ability to achieve projected financial results, product development and other anticipated benefits of the proposed acquisition; uncertainties as to whether Merit will achieve sales, gross and operating margin, net income and earnings per share performance consistent with its forecasts projected for the assets and operations proposed to be acquired from PENTAX Medical; risks and uncertainties regarding trade policies or related actions implemented by the U.S. or other countries, including existing, proposed or prospective tariffs, duties or other measures; inherent risks and uncertainties associated with Merit&#8217;s integration of businesses or assets previously acquired from third parties, including the acquisition of Biolife Delaware, L.L.C. in May 2025 and the businesses and assets acquired from Cook Medical Holdings LLC in November 2024 and EndoGastric Solutions, Inc. in July 2024, and Merit&#8217;s ability to achieve the anticipated operating and financial results, product development and other anticipated benefits of such acquisitions; forecasted results and consequences of regulatory approvals of Merit&#8217;s products; effects of Merit&#8217;s 3.00% Convertible Senior Notes due 2029 on Merit&#8217;s net income and earnings per share performance; disruptions in Merit&#8217;s supply chain, manufacturing or sterilization processes; U.S. and global political, economic, competitive, reimbursement and regulatory conditions; reduced availability of, and price increases associated with, components and other raw materials; increases in transportation expenses; risks relating to Merit&#8217;s potential inability to successfully manage growth through acquisitions generally, including the inability to effectively integrate acquired operations or products or commercialize technology developed internally or acquired through completed, proposed or future transactions; modification or limitation of governmental or private insurance reimbursement policies; uncertainties regarding enrollment and outcomes of ongoing and future clinical trials and market studies relating to Merit&#8217;s products; fluctuations in interest or foreign currency exchange rates and inflation; risks and uncertainties associated with Merit&#8217;s information technology systems, including the potential for breaches of security and evolving regulations regarding privacy and data protection; governmental scrutiny and regulation of the medical device industry, including governmental inquiries, investigations and proceedings involving Merit; difficulties relating to development, testing and regulatory approval, clearance and maintenance of Merit&#8217;s products; the safety, efficacy and patient and physician adoption of Merit&#8217;s products; litigation and other judicial proceedings affecting Merit; the potential of fines, penalties or other adverse consequences if Merit&#8217;s employees or agents violate the U.S. Foreign Corrupt Practices Act or other laws or regulations; restrictions on Merit&#8217;s liquidity or business operations resulting from its debt agreements; infringement of Merit&#8217;s technology or the assertion that Merit&#8217;s technology infringes the rights of other parties; product recalls and product liability claims; potential for significant adverse changes in governing regulations; changes in tax laws and regulations in the United States or other jurisdictions or exposure to additional tax liabilities which may adversely affect Merit&#8217;s effective tax rate; termination of relationships with Merit&#8217;s suppliers, or failure of such suppliers to perform; development of new products and technology that could render Merit&#8217;s existing or future products obsolete; market acceptance of new products; dependence on distributors to commercialize Merit&#8217;s products in various jurisdictions outside the U.S.; failure to comply with applicable </font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;padding-bottom:10pt;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">environmental laws; changes in key personnel; labor shortages and increases in labor costs; price and product competition; extreme weather events; and geopolitical events. For a further discussion of the risks and uncertainties which may affect Merit&#8217;s business, operations and financial condition, see Part I, Item 1A, &#8220;Risk Factors&#8221; in Merit&#8217;s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;), Part II, Item 1A, &#8220;Risk Factors&#8221; in Merit&#8217;s Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 filed with the SEC and Merit&#8217;s other filings with the SEC.</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.37;padding-bottom:10pt;background:#ffffff;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;">All subsequent forward-looking statements attributable to Merit or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements.  Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results. Those estimates and all other forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by applicable law, Merit assumes no obligation to update or disclose revisions to estimates and all other forward-looking statements.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">TRADEMARKS&#160;</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;">Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc., its subsidiaries, or its licensors.&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;"><u style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">CONTACTS&#160;</u></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt;">PR/Media Inquiries&#160;<br>Sarah Comstock</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;padding-bottom:10pt;background:#ffffff;margin:0pt;"><font style="color:#293849;letter-spacing:0.1pt;">Merit Medical&#160;</font><font style="color:#293849;letter-spacing:0.1pt;"><br></font><font style="color:#293849;letter-spacing:0.1pt;">+1-801-432-2864 |&#160;</font><font style="color:#0252a9;letter-spacing:0.1pt;">sarah.comstock@merit.com</font><font style="color:#293849;letter-spacing:0.1pt;">&#160;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.19;background:#ffffff;margin:0pt;"><font style="color:#293849;letter-spacing:0.1pt;">Investor Inquiries&#160;</font><font style="color:#293849;letter-spacing:0.1pt;"><br></font><font style="color:#293849;letter-spacing:0.1pt;">Mike Piccinino, CFA, IRC&#160;</font></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;margin:0pt;"><font style="color:#293849;font-family:'Times New Roman','Times','serif';letter-spacing:0.1pt;">Westwicke - ICR&#160;</font><font style="color:#293849;font-family:'Times New Roman','Times','serif';letter-spacing:0.1pt;"><br></font><font style="color:#293849;font-family:'Times New Roman','Times','serif';letter-spacing:0.1pt;">+1-443-213-0509 |&#160;</font><font style="color:#0252a9;font-family:'Times New Roman','Times','serif';letter-spacing:0.1pt;">mike.piccinino@westwicke.com</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mmsi-20251015x8k001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20251015x8k001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !# 74# 2(  A$! Q$!_\0
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M/V@/AI874MM<>/?#T4\3%70ZC%E2.HZU#_PT7\+O^B@>'?\ P8Q_XU/MJ?\
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M1D]C7VOKWPK\)ZSX#N?"<V@V*:"ULT*6D<"JL0VX#)@?*PZAASGFN _9'^"
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M^6,>6^_^>GW7WU\CT(U:*PKKUZOMO9M.-T]&T[0?,M;OWG'6*4&D_>.T\%?
M7P-X&T\P6F@6E_>2_-=:IJD2W5Y=N?O/+*X+,2>?3T K@OC-\/M-^$&G7'Q3
M\"V$/A[5]$*7.JV6G((;;5K$,!/%-$N%+A"75\;@R]>:9\=/C+JVC?%CX?\
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MK],_V!_^3<M,_P"PA>_^CC7YF3$-/*0<@NQ!'?DU^F?[ _\ R;EIG_80O?\
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M'5$@V[?+%SC=TXS][WSS5WPQ^U]\4_"'@N+PQI^OQ_88(O(M[FXMEENK>/&
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>mmsi-20251015xex99d1001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 mmsi-20251015xex99d1001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !F G8# 2(  A$! Q$!_\0
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MOBN"0QL5888<$'M7C5\1-3:B[6/U'*,FPDL)"K7AS.2OK^1]UI_P52^([_\
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M_P#QRODL"@K[4OKN(_G92X4R;_H&C^/^9]:?\/)_B!_T+7AW_OF?_P".4?\
M#R?X@?\ 0M^'?^^9_P#XY7R9MHV^U+Z[B/YV/_53)O\ H&C^/^9]9_\ #R?X
M@_\ 0M^'?^^9_P#XY6==_P#!37XE6C?-X6\-,AZ,%N,?^C*^7=E(\0=2K $'
MJ#5+'5UO(RJ<(Y1)>[ATG\_\SZ<'_!4'XB'_ )E?PU_WS<?_ !RGC_@I]\1#
M_P RQX:_[YG_ /CE?)-[H[1DO!DKW3N/I6>#6ZQE9[2/'GPSEM*7+/#K\?\
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MQ _Z%OP[_P!\S_\ QROD-E:-L."I]",4!JT^N8C^<Y_]6<FV>&C^/^9]>_\
M#RGX@?\ 0M^'?^^9_P#XY2_\/*/'_P#T+?AW_OF?_P".5\A[J=FE]<Q'\[+7
M#&2_] T?Q_S/KK_AY1X__P"A;\._]\S_ /QRE_X>3^/^WAOP[_WS/_\ '*^1
M=U&^E]<Q'\Y7^J^2_P#0-'\?\SZY_P"'D_C_ /Z%OP[_ -\S_P#QRE_X>3^/
M_P#H6_#O_?,__P <KY&W^]&^CZYB/YV/_5?)?^@:/X_YGUS_ ,/)_'__ $+?
MAW_OF?\ ^.4?\/)_'_\ T+?AW_OF?_XNOD;?1O%'US$?SL/]5\E_Z!H_C_F?
M7/\ P\G\?_\ 0M^'?^^9_P#XY1_P\F^('_0M^'?^^9__ (Y7R-O%(7H^N8C^
M=B_U8R7_ *!H_C_F?77_  \G\?\ _0M^'?\ OF?_ ..4A_X*4>/Q_P RWX=_
M[YG_ /CE?(NZDW4?7,1_.3_JQDO_ $#1_'_,^NC_ ,%*?B!_T+?AW_OF?_XY
M2?\ #RKX@?\ 0M^'?^^9_P#XY7R+NII:G]<Q'\[)_P!6,E_Z!H_C_F?79_X*
M5_$#_H6_#O\ WS/_ /'*0_\ !2SX@#_F6O#O_?,__P <KY$W4TFG]<Q'\Y#X
M9R;_ *!H_C_F?7G_  \M^(/_ $+7AS_OF?\ ^.4A_P""E_Q '_,M>'/^^9__
M (Y7R&6HC22XE6*&-II'.%1%+,Q] !UI_6\1_.S)\-Y,O^8>/X_YGUV?^"F'
MQ!'_ #+7AS_OF?\ ^.4P_P#!3/X@_P#0L^'/^^9__CE?(<\<EM*T4T;Q2*<,
MDBE6'U!Z4_3].O=9NEM=/LKB_NF!(@M(6E<@=3M4$U:Q6(_F9A+A[)DK_5XV
M^?\ F?6Y_P""FGQ"'_,L^&_^^9__ (Y2'_@IO\0A_P RSX;_ .^9_P#XY7R%
M-!/!<M;2PRQ7*MY;0NA#ALXVE>N?:G:KIE]HES]GU&QNM/N"H;R;N%HGP>AP
MP!Q[T_K5?^9F+X?R?;V$?Q_S/K@_\%.?B$/^99\-_P#?,_\ \<IK?\%/?B$!
M_P BQX;_ .^9_P#XY7Q_<VUS;1Q236\T,4HS&\B%5<>H)'/X53+EB  6). !
MWI_6J_\ ,8O(,HZ4(_C_ )GV0?\ @J!\0P/^18\-?]\S_P#QRHV_X*B?$0?\
MROX:_P"^;C_XY7R%J^D:EH4D<>IZ==Z;)(N]$O+=X2Z^H# 9'N*@FT;5(X&F
M;3;U80N\R&V<*!ZYQC'O5_6:_P#,SEEDF46NJ,?Q_P S[ ;_ (*D_$1?^97\
M-?\ ?-Q_\<J%O^"I_P 1P0!X5\,DGH-MQS_Y$KY#TGPUK'B&"XGT_3;R[MK<
M;IYX+=Y$B'JQ4''XU+;645J-R_,_]\]:'BJR^T$.'\MJ/2BK?/\ S/L.W_X*
M>?$IEW3>%O#*>BA;C/X_O*D/_!3WXB#_ )ECPW_WS/\ _'*^0GM+C[-]J^SR
MBUSM$_EG83Z;L8S58*TTBI&K.[$*JJ,DD] !4_6J_P#,='^KV4I6]@OQ_P S
M[#_X>@?$3_H5_#7_ 'S/_P#'*:?^"H?Q%'_,K^&O^^9__CE?'\=C=7%\ME%:
MSRWC/Y:VR1LTI;^Z% R3[8J/4+&ZTN[DM;VVFL[J,X>"XC:.1#Z%6 (I_6:_
M\QD\ARF]O81_'_,^P6_X*C?$4=/"WAK_ +YN/_CE:/A[_@J?XMM]3A.N^#-&
MN]-W#S5T^:6&8+W*ERRY]B.?45\7:KH^HZ(T2ZCI]WI[3)YD2W<#Q%U_O+N
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M<^RO%<WL:Z?*FWNM%N]4MO(\? S3L5]G#_@F5XF _P"1WTG_ , Y?_BJ4?\
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ML@0DG@,<*3_%CFG:#\#]6UGPQKNJS74.G7&DR3126%PI$A>(9D4\_*1]#ZG
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MGD#->9_$KXO>$?'^H7NL_P#"':A%X@D:,P3WFL^?:P*C#;$+<1*/*"@J$!
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MZ:R6M]U?N>AVGA;4_@9X6^*NO6>K+?Z\MOI4>E>([-F#M97[-(UU&Q^9'D1
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MY1DP. 1*C9&>#5QA33LW_5[')7Q>-E2<HQLUMHWK[-RO]^B5M_,^>=<TB_\
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M7.@/G=I0O9!:G)R1Y0.W&><>M*,HQ*KT*]>/1.S7R=M?73;\3T+5O ?A/4O
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MA]GHHKDQ5*#DI6U/HN'L?B8494E/W8[+32X@_P""?WQ&_P"@OX7_ / NY_\
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M_B4!_P ACPK_ .!ES_\ (]%%=#IP['A1QV(_F_!?Y$J_\$_/B2N/^)QX6_\
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MF/\ L"_$5NFK^&/_  +N?_D>BBG[*'8SEC\3_-^"_P B"3]@#XCL.-8\+_\
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&CNWJV?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>mmsi-20251015.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.1.0.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/17/2025 3:58:02 PM-->
<!--Modified on: 10/17/2025 3:58:02 PM-->
<xsd:schema targetNamespace="http://www.meritmedical.com/20251015" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:attributeFormDefault="unqualified" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:mmsi="http://www.meritmedical.com/20251015">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20251015_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="mmsi-20251015_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>mmsi-20251015_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.1.0.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/17/2025 3:58:02 PM-->
<!--Modified on: 10/17/2025 3:58:02 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity File Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Incorporation, State or Country Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Tax Identification Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Address Line One</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, City or Town</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, State or Province</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Address, Postal Zip Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">City Area Code</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Local Phone Number</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Written Communications</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Soliciting Material</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pre-commencement Issuer Tender Offer</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Title of 12(b) Security</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Trading Symbol</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Security Exchange Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Emerging Growth Company</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>mmsi-20251015_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  11.1.0.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 10/17/2025 3:58:02 PM-->
<!--Modified on: 10/17/2025 3:58:02 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="mmsi-20251015.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638963134819869100" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentPeriodEndDate_638963134819869100" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityFileNumber_638963134819869100" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638963134819869100" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode_638963134819869100" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber_638963134819869100" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressAddressLine1_638963134819869100" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressCityOrTown_638963134819869100" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince_638963134819869100" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode_638963134819869100" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_CityAreaCode_638963134819869100" order="11" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_LocalPhoneNumber_638963134819869100" order="12" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_WrittenCommunications_638963134819869100" order="13" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SolicitingMaterial_638963134819869100" order="14" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementTenderOffer_638963134819869100" order="15" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer_638963134819869100" order="16" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_Security12bTitle_638963134819869100" order="17" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_TradingSymbol_638963134819869100" order="18" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_SecurityExchangeName_638963134819869100" order="19" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany_638963134819869100" order="20" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638963134819869100" order="21" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638963134819869100" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638963134819869100" order="22" use="optional" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 15, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 15,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-18592<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Merit Medical Systems,&#160;Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">87-0447695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1600 West Merit Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">South Jordan<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">UT<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">84095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">253-1600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MMSI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000856982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mmsi-20251015x8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>mmsi-20251015.xsd</File>
    <File>mmsi-20251015_lab.xml</File>
    <File>mmsi-20251015_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" original="mmsi-20251015x8k.htm">mmsi-20251015x8k.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mmsi-20251015x8k001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "mmsi-20251015x8k.htm": {
   "nsprefix": "mmsi",
   "nsuri": "http://www.meritmedical.com/20251015",
   "dts": {
    "schema": {
     "local": [
      "mmsi-20251015.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "mmsi-20251015_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mmsi-20251015_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "mmsi-20251015x8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20251015x8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "mmsi-20251015x8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.meritmedical.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0000856982-25-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000856982-25-000050-xbrl.zip
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M\NUYM =^!A@>F&+0= >DR2RWC]C$CXASX</GI<^D!<"#P)@^2$_ ' -0';B
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MAL,X]9XYNM1(2NA3W! E*/SSE9PBIW<Z;K/CX4G]Z*<17#V)%^>6YBKO1]N
M Q$IKSJXMD#NCVIG:]WL/R=&.CWEMUK+PGZO%DI[66KE=H*Y/;'(6668=%/^
MX7#]PY9OM=WR[6[Y=HOB;M%BDZ(HK1QCS8:JR&HCK>K-!A1M-5I9EC/2K;2A
MI)OKVEOYO%NH7DUE_3Z0+@M5U:NG%Z6;VUIEC1L+5A5!VLSD?978YR..[N".
MST0J[ NVINS/._^#KZ#S9#)#V)#BNK<H&2S:^8JI$=!EDW6HU1IEV&.^:%0
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M4E_[("WQQ[=JAB;Z3P(2C'E1RFM-3+,"BV_PTMB6>8]%%GRZY5Q0:1+(Z9=
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MI86W4J.DU,1 Z3>''7J]<<MO$9OB*&Y6^JQ(;..OX^\L/Z-41=6%LV#)QII
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M5WS\DD3.7]S^2J_->2Q;H3[$<&?X=H]CK=IME6R(5W)K#&*AO#%(]>0?(@"
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MC]2H2R 1F!M2"9 XO@-%\^^5J[E5P:#:>#@&S#:<+R?F[_N5Q^%:7?6=:'"
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M?&#%@VC1RG DK6C^F_^?#Y@X^]\ 4$L#!!0    ( '. 45L%-C7>$Q\   "
M   8    ;6US:2TR,#(U,3 Q-7AE>#DY9#$N:'1M[5UY<QLWEO\J6">;V+4D
M3>JP#GI<(\NRK8QM>21Y,O/7+M@-DK":#:;1+8JI_?#[#@"-;HJ2;T>S255L
MJ0\T\/".W[O@Q__1[1[E4YDG*A4OSU^_$JE)JIG*2Y$42I9P=:'+J3@W\[G,
MQ6M5%#K+Q--"IQ,EQ&#0&_3ZO=V-;O?)8QCJT+UC\GTQZ#\<[#S<Z&]LB_[F
M_O;._O8C\?:UN/_N_/ !/CXM9QG\J63ZY/%,E5(D4UE85?[EWKOSY]W=>T\>
ME[K,U)/'#_W?_.S(I,LGCU-]*6RYS-1?[LUD,=%YMS3S_<W^O!S"FP_A=NN9
MJ^Y"I^5T?]#O_^=P+M-4YY-NIL;E/BQBYU%]K="3:7W16%UJ6$ZA,EGJ2X6C
M1^,FF9+%_LB4TV'[$]>].??OC4U>=L=RIK/E_L^',M.C0O_<^?FERBY5J1,)
M/UN9VZY5A1[_/*3'K?Y=P=BPPDSGJCM5/-'>8&]8JJNR"Z-,X'-X=<@TV8>'
M!?Z_T]OFGW 2HVLG<:YGRHHW:B%.S4SF, &Z@A.)YK#@CXY,EL)01_]\>?ST
M^%SL[?4&CQ^.@.[S+[+&P<H:-W:C)>$BI,CE##[RWR^SB^VMC>V=C;T^;KQL
MW=K8V]K:VN@/W#W\R*<M'P;0LXFP10+<-+.ZBYP]Z ^VK]35WEX*>S[HO9]/
M[@F9 0N_*.1\JI-[_ENIMO-,+O=U3NL:92:Y&+K5[6SW=K9QQ<B,$7,"5Y5F
MMM_GNZO\A R/U&"FVWJTZW@?U_7%MF*5W1I;0=PUZ'\-Y@)=HTO0."G,+Q-G
MP-M6'%A0$.)M58"NL$H<3 JE2%F1DGI[].;\X)_AE=((F?Q6Z4*)PPUQ6"S-
M4YEEQN3B7"73W&1FLA2!;4LYRI08F2)5Q5_N]>^)1&69VXKPNYW+Q/_NULEO
M=!.397)NU;[_8?@EV7]SQ]'<,P7M2Z3X\%=:01>XS%3E_EA?J708Z2.>IQ>?
MLH#_4[\&]YAGH#*-;W["1M:L<ZD*7&OFE!/I*9CO<#'5I>HB.=5^;A8@+<-H
M$H[L;K(__;#W:&=OV)Y7\Z''^HO,EW_%@?9U"7-.&IR9FV(F,_@:\R%Q%TNE
M6)@J2X6Z BN9"F+=GW[8W1CL#*TXRE-C$S-?BKDIRK')M&%^!8.J\]Q<DCB+
M5%WJ1"'7EFA%Q1PN VM;8:OQ& ;,)V)<F)EX*HM"E7!=63.?RDEE!7X33) J
MQ$3:LC Z+Y4M=0Y" (J'-M[V?OIA\*@/5-1NAQ\B#SPDIOG:W/\QN[!QG7UK
M,O^'\7YD$]]70(WQ\D]Q^&;BH*V8%^:]2A -HB).4R'G<.E*SP A9DOQXR,!
M<\KP8;C_XV[XS8Q%H2Y57BF0#@%6]A'^+<6%6CKV!JE0!:MO8(,+^'0Y!8')
MX*U"3F"!3?E35QJ%82(2,YNI(M$@%F-CRCG(5-E;(Q#7X\M! U]^!_/Z.?CE
M[.3=^4OQR\GILX,W'?&NE-...$G*GAAL=P3A]/LO7IT\/1)OCGX]^_7X].B!
MZ'9%RPPO;:EFMB..\Z0G[K\Y.'MV\/=]\?KUV?&##FS2)#,C> Q0,4@7;B5@
M]JR<)A*,<!FL;@>V/)5+T%NYJ<CU@$^ 11<6I )^DZ ,QSK7I!<E,=?<VWS9
MLOGPD[S"+QW WL(<>6HX%UN-K$ZU+)9XF\$!*,&=K:%?CG\V0@J@15MH ?AH
M:W=CZ/4SZEJ"8,C8844]<0XO)AF -& T^!R. ^P.J V?*V#W9>(E ZQ$$ R3
M)%4ATHKT.[XT-E4!Z_JMDD7)),2MZ>!J4)S(/L!CA4J4!KXPA5A((%,A[J.4
M) GH-?3FF#IN%I<@E@;@DYO7.HH^P <24%$2ADI 9P(G ?'\JA*3IR3=MO>=
M0>;G2 &JA8W^\#S>GUAS%6J< 9W;2@1UARZ)[TB=70*1D2@S8%-0@J#0='XI
M+3*L-5E%9(*]O-$BBU^5&Q\83UTEVO'$0F7P.25R6$>IY$S,U&P$+Q#O.8@!
M7%+#B8Y0L[E9,$B83Y=6@Y*#[\-8>H;[KSR:@/=*'-L"8"FR%(R,ZA!%!D-A
MI0;H FPWE>)%3QP4L 23=UJ$>%LHD"H<"J=Q>'1R=YDAMKKS0G7)[MY[LI8U
M0'1Q'_.4MPGV5>43$*B\12+OJJ'=0GE;9[60@"2=J1)FCKM9H<Y3M@:!,U.H
MM4@0QU9P!;D5)7<*.Z83_SE&AZ!^B:6K*V0\A?)^_\71Z;,'-X'&4EL+YC?B
MU/,5M0CZ,$.]@Z*1P^M9!E09@R;YG309SGY&DX:UI 7*10E[J)#%P<)*H@\3
M0"4P,1@.)E&QCH3%5/E"YOBP->/23:@GQ)WE-0!)I$.0<'J"A+ZL"=P1N"5L
M"T RD:-P;S,4:1%MI)U/=9Z@64AA?T5ND#(P;W@>]#X0LLS MN+^+' 3 *VG
M-:>0.D^FN!_$BLP^WH< 9<2?!29W\W#\A,JM@P8ZD:@=;965R-BX+@.^!QOX
MR#B@J8+/2!O//)4S^*'CG9<:F_GO=X@9$C1=Q;7L1AQE;QS HN;,\&\)",3:
MKB,XZ.6DRF01T9M8'F0%>*R Z84G@(2@Q"7(R,$_ /_899X"_6#BHV7-W*2&
M,PVJ7Q*NE"-&PNPDP?[I#,F-@=(9F%(TI]ZZHY!-0%<0)+%540#^2>DFBQS+
M0 5D[MUE7G=&]E=P*8%0"H4?&2M C@729JJR.=DQLG%F7@)%?U<Q2D?(=,D:
MT:G2&7"?'K&GT$W1V2P^2+U&1I& $>E5_*1A,TES(92*-AN^I(N@=IL&\GD!
M2NEM3[R2,S(2%:"CMHT\G$H-#)%[P/74R"+]=]A0D,D:\Q)B'RF%>ISA"\$/
M ! UWO9(.Y#F/6QX#IX<($H J1O]P<ZUTCXU64HNY QM@TP*8U&J 4=/E*,J
M&&L%."M!OQ(\4\G(%#"5P&V<9VCKV/=T7@9[B>S/$ ..&.XCS)HBWL*M/]SH
M@.W!\"PN1I=HS4&_EL".-1^4A/Z?&01_OX'4_@,7DY>="!RM4* GO% @_^'
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M<>(YL/R+@X.WH"'1QE.L#3\:KH-Y0#5C\3O"3F$RY "V9MSO;37F#!?ZL$"
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M\NV'!%%1 "WF7$\?^+7=2:=]_;/S-5SI)Z.0LJ(Z_4Z8^G43YJ2PJU*.FP)
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M>>4F1VAU6,7I? S(+<=0$2K;2,4XY3>3:2/T9F]W 6K$+W[ZK3) W<*=QU
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M,#(U,3 Q-5]L86(N>&UL4$L! A0#%     @ <X!16S 9-JQF!   Q24  !4
M             ( !SP@  &UM<VDM,C R-3$P,35?<')E+GAM;%!+ 0(4 Q0
M   ( '. 45O#\0Q('AT  *C-   4              "  6@-  !M;7-I+3(P
M,C4Q,#$U>#AK+FAT;5!+ 0(4 Q0    ( '. 45O;_XO$=RL   LM   7
M          "  ;@J  !M;7-I+3(P,C4Q,#$U>#AK,# Q+FIP9U!+ 0(4 Q0
M   ( '. 45L%-C7>$Q\   "    8              "  616  !M;7-I+3(P
G,C4Q,#$U>&5X.3ED,2YH=&U02P4&      8 !@"2 0  K74

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>mmsi-20251015x8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mmsi-20251015.xsd" xlink:type="simple"/>
    <context id="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000856982</identifier>
        </entity>
        <period>
            <startDate>2025-10-15</startDate>
            <endDate>2025-10-15</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_h6iQ8IudOk6ynxSmtdpOPg_2_1">0000856982</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_Y1OhEsJcSESd0zZXucP2dg_3_1">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_PeEobsZFCUmeN3PI8pEwJg">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_RiGWjHkifkWlwYP1SMoYaQ">2025-10-15</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_Cp4ESXKYTkClvDG-eVuX5w">Merit Medical Systems,&#160;Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_0QYXtQzqrkmlkOHneteSXA_1_0">UT</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_L5M78zxbOES_JlG4BI5T1Q_1_2">0-18592</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_JknZHsZx9UCPS2VBQCxWpg_1_4">87-0447695</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_rJIaT4g3jEWS-lDfsL-Fjw_1_0">1600 West Merit Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_4AE7UOaOpk24VuR1R8bMFg">South Jordan</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_S_vQ-qoSMkiRLlzK-LFHcA">UT</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_LLSe1xf-KEyyYzokxveY5A_2_2">84095</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_q2X3HmtVz0y1eLnTGpC-Og">801</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr__AQ3VdovS0mk_ZKpZFinWA">253-1600</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_MIR3jIR7uEyB2wgNlFHm1w">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_i8hoaXdu-EeKIpdi4thLPA">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_Do9t8_MpSEySroVl-u3x2A">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_WlyWk8XlA0a4Z4AVizavtA">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_q_E3GkRBTk-FlmAN5DhzDQ_2_0">Common Stock, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Tc_9GqSklqLPk-Z3JE-pDj_Ww_2_2">MMSI</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_-Q8uExkNm02dM63Vov-0qw">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="Duration_10_15_2025_To_10_15_2025_WAmXlC2PLUG9Wn0ldUPJ2w"
      id="Narr_GMrdmmNx-Emx0CtI0iUo6A">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
